COVID-19 with baricitinib-induced symptomatic creatinine kinase elevation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

COVID-19 with baricitinib-induced symptomatic creatinine kinase elevation

Published:2022-01-13 Issue:3 Volume:115 Page:155-156
ISSN:1460-2725
Container-title:QJM: An International Journal of Medicine
language:en
Short-container-title:

Author:

Saishoji Y¹^ORCID,Izumi Y¹,Otsuka Y¹,Yura H²^ORCID

Affiliation:

1. From the Department of General Internal Medicine, National Hospital Organization Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki 856-8562, Japan

2. Department of Respiratory disease, National Hospital Organization Nagasaki Medical Center, Kubara 2-1001-1, Omura, Nagasaki 856-8562, Japan

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

https://academic.oup.com/qjmed/advance-article-pdf/doi/10.1093/qjmed/hcac004/42274420/hcac004.pdf

Reference5 articles.

1. Symptomatic elevation creatine kinase following treatment of rheumatoid arthritis with baricitinib;Anjara;Clin Rheumatol,2020

2. Characterization of creatine kinase levels in tofacitinib-treated patients with ulcerative colitis: results from clinical trials;Panaccione;Dig Dis Sci,2021

3. Acute steroid myopathy: a highly overlooked entity;Haran;QJM,2018

4. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study;Chen;Lancet,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Baricitinib/dexamethasone;Reactions Weekly;2022-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP